Oncotarget: C. Elegans Sniff Out Early Pancreatic Cancer

(51)

Behind the Study: Molecular Dialogue Between Tumor Cells and Fibroblasts | Oncotarget

(7:)

Oncotarget: PIP3-binding proteins promote limit survival in C. elegans

(13:4)

Oncotarget: Therapeutic strategy for drug-resistant thyroid cancers

(7:35)

Oncotarget is Again on MEDLINE

(2:21)

What tumors eat -- and how to poison them | Dr. Christal Sohl | TEDxTulsaCC

(10:15)

Science and the Future of Humanity | Episode 1713 | Closer To Truth

(26:48)

Communication of tumour cells with the microenvironment

(3:59)

Oncotarget: Survival in patients with lung adenocarcinoma harboring \

(6:58)

\

(3:51)

Cancer Registry Management Info Session

(11:40)

Integrative Metabolism mTOR, rapamycin, autophagy and fasting

(20:36)

Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria

(12:54)

Wnt/β-Catenin Signaling Pathway

(4:3)

New Data on the Management of Recurrent Glioblastoma and High Grade Glioma

(6:20)

Oncotarget | Effects of Metformin and Rapamycin in Pancreatic Cancer

(1:)

Oncotarget: ONC201, TRAIL, and Breast Cancer

(52)

Oncotarget | CCL20 and Signaling Pathways in Colorectal Cancer

(52)

Oncotarget: Combination Therapeutics Inhibit Breast Cancer Resistance

(41)

Oncotarget: Novel insights into the prognostic evaluation of prostate cancer

(29:15)

C/EBPβ Cooperates with MYB to Maintain Oncogenic Program of AML Cells | Oncotarget

(58)

Oncotarget: Dynamic Changes Throughout Pancreatic Cancer Treatment

(53)

Oncotarget: EMTs Produce Endothelial Cells \u0026 Tumor Growth

(46)

Oncotarget: Can Precision Oncology Improve Patient Survival AND Cut Costs?

(45)

Variants and Polymorphisms in Bladder Cancer | Oncotarget

(59)

Oncotarget: The Oncopig Cancer Model and Liver Cancer

(51)

Oncotarget: CRISPR Used in Triple Negative Breast Cancer Research

(59)

Oncotarget: MEND Study Analysis of Nigerian Breast Cancer

(42)

Oncotarget: Bacterial Therapy Experiments in Prostate Cancer

(47)